As per available reports about 70 journals, 40 Conferences and 19 work shops are presently dedicated exclusively to Bioanalysis and about 240 articles are being published on the current trends in Bioanalysis. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Bioanalysis and Biomedicine are being carried out. As reported in above mentioned article, Bioanalysis is a sub-discipline of analytical chemistry covering the quantitative measurement of xenobiotics (drugs and their metabolites, and biological molecules in unnatural locations or concentrations) and biotics (macromolecules, proteins, DNA, large molecule drugs, metabolites) in biological systems.
The Journal of Bioanalysis & Biomedicine is an academic journal – hosted by PrimeOA Publications International – a pioneer in open access publishing–and is listed among the top 10 journals in Bioanalysis. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Bioanalysis & Biomedicine provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Bioanalysis and bioinformatics, thus bridging the gap between researchers and young scientists.
PrimeOA Publications International Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, world class exhibitions and poster presentations. PrimeOA Publications International Conferences invites all the participants across the globe to attend the 6th International Conference and Exhibition on Biologics and Biosimilars The most awaited event would be staged during October 20-22, 2016 at Houston, USA. Biosimilars International Conference-2016 provides an in-depth discussion of key industry issues essential to biosimilars including cost effectual development and progression of methods, operation of clinical trials, appraising safety and quality, key strategies for dissolution testing, overcoming regulatory and legal issues and achieving access to emerging markets and commercialising biosimilars.